Trends in survival of patients diagnosed with cancers of the brain and nervous system, thyroid, eye, bone, and soft tissues in the Nordic countries 1964–2003 followed up until the end of 2006

Figures & data

Figure 1. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for eye cancer by sex and country. Nordic cancer survival study 1964–2003.

Table I. Trends in survival for eye cancer by sex and country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1968	168	60 (49–73)	92	64 (45–92)	5	*	100	63 (52–75)	241	59 (51–70)
1969–1973	170	66 (53–82)	98	64 (45–92)	7	*	111	63 (52–75)	242	63 (53–74)
1974–1978	156	65 (53–79)	111	70 (60–83)	8	*	101	60 (46–78)	257	65 (54–78)
1979–1983	158	57 (47–69)	110	70 (60–83)	6	*	135	74 (61–91)	235	69 (61–79)
1984–1988	152	64 (53–77)	99	48 (39–61)	5	*	116	70 (58–84)	225	60 (52–69)
1989–1993	161	63 (52–76)	151	76 (65–88)	5	*	131	77 (65–91)	254	70 (62–80)
1994–1998	192	59 (51–69)	144	86 (72–102)	4	*	138	76 (65–89)	270	81 (73–90)
1999–2003	203	69 (61–78)	154	83 (74–93)	5	*	155	76 (68–85)	292	77 (71–84)
Women
1964–1968	142	57 (49–65)	111	64 (54–76)	4	*	90	68 (57–81)	225	69 (58–82)
1969–1973	154	57 (49–65)	106	60 (50–71)	1	*	83	68 (57–81)	226	69 (60–79)
1974–1978	136	58 (49–67)	139	60 (50–71)	5	*	104	68 (57–81)	208	69 (60–79)
1979–1983	132	65 (54–77)	114	68 (57–82)	4	*	108	60 (49–73)	192	68 (59–77)
1984–1988	141	62 (52–72)	122	65 (56–77)	2	*	101	72 (61–85)	236	68 (61–76)
1989–1993	154	61 (52–72)	155	68 (60–78)	4	*	138	69 (60–80)	242	72 (64–80)
1994–1998	174	68 (60–77)	146	82 (72–93)	4	*	148	78 (69–88)	264	71 (64–79)
1999–2003	179	70 (63–77)	132	78 (71–86)	5	*	148	77 (70–84)	261	74 (69–80)

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival

*Too few patients to calculate survival, see ref. [17].

Table II. Trends in 5-year age-specific relative survival in percent after eye cancer by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–49	50–59	60 – 69	70–79	80–89	90+	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	85	60	65	57	36	*	78	72	53	57	28	*
1969–1973	77	58	59	57	96	*	78	72	53	57	28	*
1974–1978	83	84	61	41	83	*	86	67	68	60	0	*
1979–1983	86	54	67	58	20	*	88	64	86	43	52	*
1984–1988	85	71	63	60	49	*	94	74	64	53	34	*
1989–1993	87	62	58	55	67	*	86	81	55	60	33	*
1994–1998	83	76	71	54	12	*	96	85	58	72	35	*
1999–2003	89	70	73	62	60	*	94	83	69	66	44	*
Finland
1964–1968	85	66	54	59	76	*	80	91	55	83	0	*
1969–1973	85	66	54	59	76	*	92	68	65	52	30	*
1974–1978	85	88	84	63	28	*	92	68	65	52	30	*
1979–1983	85	88	84	63	28	*	93	63	62	84	32	*
1984–1988	91	77	54	33	0	*	101	63	85	59	17	*
1989–1993	88	71	88	72	58	*	77	64	80	83	17	*
1994–1998	90	88	74	80	113	*	88	82	78	76	96	*
1999–2003	85	78	71	80	113	*	89	77	79	75	78	*
Norway
1964–1968	82	71	67	65	26	*	82	76	70	60	62	*
1969–1973	82	71	67	65	26	*	82	76	70	60	62	*
1974–1978	101	63	59	48	46	*	80	82	86	49	48	*
1979–1983	93	85	63	69	80	*	90	73	66	45	37	*
1984–1988	85	60	74	78	48	*	94	77	60	80	56	*
1989–1993	81	88	77	69	74	*	90	83	64	65	53	*
1994–1998	95	85	62	73	82	*	92	91	73	83	55	*
1999–2003	95	76	87	69	56	*	86	85	80	76	54	*
Sweden
1964–1968	80	56	68	59	31	*	85	81	58	55	88	*
1969–1973	78	81	61	48	59	*	85	77	61	56	85	*
1974–1978	79	61	67	46	89	*	85	84	68	51	76	*
1979–1983	89	69	71	68	54	*	91	88	64	54	58	*
1984–1988	89	58	60	67	26	*	84	67	78	64	45	*
1989–1993	88	69	60	68	80	*	89	68	71	74	58	53
1994–1998	85	82	68	72	117	*	91	73	71	65	64	*
1999–2003	83	78	65	80	87	81	91	71	68	76	70	*

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival

*Too few patients to calculate survival. Iceland not shown for the same reason, see ref. [17].

Figure 2. Trends in age-standardised (ICSS) excess death rates per 100 person years for eye cancer by sex, country, and time since diagnosis in Nordic cancer survival study 1964–2003. No Icelandic curves. Too few partients to calculate survival for Iceland.

Figure 3. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for cancers of the brain & central nervous system by sex and country. Nordic cancer survival study 1964–2003.

Table III. Trends in survival for cancer of the brain & nervous system by sex and country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1968	1 010	20 (18–23)	605	*	29	*	761	21 (18–25)	2 015	25 (23–27)
1969–1973	1 113	22 (20–25)	639	*	34	*	762	21 (18–25)	2 160	27 (25–29)
1974–1978	1 280	26 (23–28)	726	33 (27–41)	45	*	859	27 (24–30)	1 912	27 (25–29)
1979–1983	1 412	32 (29–35)	1 051	46 (42–51)	43	*	975	32 (28–35)	2 155	35 (33–37)
1984–1988	1 546	35 (33–38)	1 214	46 (43–50)	58	35 (28–45)	1 140	36 (33–39)	2 538	38 (37–40)
1989–1993	1 747	38 (36–41)	1 368	43 (40–46)	83	35 (28–45)	1 164	38 (36–41)	2 707	44 (43–46)
1994–1998	2 026	44 (41–46)	1 458	47 (45–50)	79	40 (34–48)	1 217	42 (39–45)	2 740	48 (46–50)
1999–2003	2 085	46 (44–48)	1 612	52 (50–54)	74	40 (34–48)	1 588	45 (43–47)	2 613	48 (47–50)
Women
1964–1968	935	32 (29–36)	606	35 (31–39)	24	*	596	25 (21–29)	2 204	35 (33–37)
1969–1973	1 070	31 (28–34)	681	42 (38–47)	29	*	598	27 (23–31)	2 382	39 (37–41)
1974–1978	1 298	35 (33–38)	934	44 (41–48)	34	46 (35–61)	780	35 (32–38)	2 045	42 (40–45)
1979–1983	1 426	44 (41–47)	1 398	58 (54–61)	64	46 (35–61)	955	43 (39–46)	2 276	51 (49–53)
1984–1988	1 600	46 (44–49)	1 650	61 (58–64)	58	56 (47–67)	1 099	51 (48–54)	2 821	55 (53–57)
1989–1993	1 862	55 (53–57)	1 708	58 (56–61)	80	56 (47–67)	1 233	59 (56–61)	2 834	57 (56–59)
1994–1998	2 237	59 (57–61)	1 960	62 (60–65)	87	65 (55–76)	1 467	59 (57–62)	3 171	65 (63–67)
1999–2003	2 482	61 (59–63)	2 351	67 (65–69)	92	60 (52–69)	2 027	67 (65–69)	3 071	68 (66–69)

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival

*Too few patients to calculate survival, see ref. [17].

Figure 4. Trends in age-standardised (ICSS) excess death rates per 100 person years for cancers of the brain & central nervous system by sex, country, and time since diagnosis in Nordic cancer survival study 1964–2003.

Table IV. Trends in 5-year age-specific relative survival in percent after cancer of the brain & nervous system by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–49	50–59	60–69	70–79	80–89	90+	0–49	50–59	60–69	70–79	80–89	90 +
Denmark
1964–1968	35	18	12	11	0	*	45	33	26	19	16	*
1969–1973	39	19	13	10	0	*	47	37	20	15	5	*
1974–1978	46	20	13	13	0	*	49	37	31	19	9	*
1979–1983	49	29	23	12	21	*	60	43	41	29	8	0
1984–1988	55	38	21	15	10	*	65	44	38	30	20	*
1989–1993	60	36	25	21	16	*	72	54	48	38	28	0
1994–1998	63	46	34	22	18	0	74	69	51	41	23	0
1999–2003	68	43	35	24	21	0	77	67	57	40	25	25
Finland
1964–1968	34	22	13	7	*	*	49	42	34	10	0	*
1969–1973	46	25	17	27	*	*	56	42	44	26	0	*
1974–1978	44	31	18	25	47	*	60	40	44	27	16	*
1979–1983	65	44	33	28	37	*	72	62	53	37	31	*
1984–1988	68	48	32	32	8	*	72	69	55	49	25	*
1989–1993	65	49	33	14	8	*	77	66	52	33	15	*
1994–1998	71	51	30	21	30	*	79	75	56	38	20	0
1999–2003	72	58	39	27	27	*	80	78	66	46	22	*
Iceland
1964–1968	41	26	16	14	*	*	46	62	18	*	*	*
1969–1973	41	26	16	14	*	*	46	62	18	*	*	*
1974–1978	47	19	49	25	*	*	55	44	49	10	79	*
1979–1983	47	19	49	25	*	*	55	44	49	10	79	*
1984–1988	54	32	19	24	21	*	59	62	54	35	78	*
1989–1993	54	32	19	24	21	*	59	62	54	35	78	*
1994–1998	60	47	21	22	20	*	73	77	61	56	24	*
1999–2003	60	47	21	22	20	*	74	73	44	47	27	*
Norway
1964–1968	30	16	16	13	19	*	35	27	20	16	0	*
1969–1973	30	16	16	13	19	*	38	28	25	12	0	*
1974–1978	46	21	17	16	0	*	51	41	29	12	0	*
1979–1983	49	33	22	11	15	*	60	45	31	24	26	*
1984–1988	58	36	23	18	0	*	71	56	45	25	9	*
1989–1993	62	39	25	18	8	0	77	62	49	42	19	0
1994–1998	63	42	28	20	19	*	74	69	49	44	28	0
1999–2003	65	45	29	32	28	0	79	72	61	54	39	27
Sweden
1964–1968	43	26	16	7	0	0	49	40	32	17	2	0
1969–1973	47	25	17	7	3	0	53	43	35	19	11	0
1974–1978	47	22	21	9	5	0	57	48	37	25	11	0
1979–1983	55	30	27	17	5	*	69	53	40	37	15	*
1984–1988	61	34	26	22	13	*	72	60	47	36	19	52
1989–1993	65	42	35	29	12	*	73	61	49	45	23	0
1994–1998	67	46	33	32	35	*	80	70	55	52	40	52
1999–2003	67	46	35	33	34	*	80	71	60	56	44	13

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival

*Too few patients to calculate survival, see ref. [17].

Figure 5. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for thyroid cancer by sex and country. Nordic cancer survival study 1964–2003.

Table V. Trends in survival for thyroid cancer by sex and country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1968	122	50 (41–62)	111	53 (48–59)	13	*	138	51 (44–60)	345	56 (51–62)
1969–1973	143	45 (38–53)	150	53 (48–59)	24	*	167	69 (63–76)	419	58 (53–62)
1974–1978	149	47 (40–56)	220	65 (59–72)	23	92 (80–105)	176	72 (65–79)	422	65 (61–70)
1979–1983	154	51 (44–59)	186	74 (67–83)	30	92 (80–105)	221	81 (76–87)	431	70 (66–75)
1984–1988	157	54 (47–62)	257	72 (66–79)	27	87 (78–98)	201	77 (70–84)	439	72 (68–77)
1989–1993	132	68 (59–79)	264	77 (71–84)	24	87 (78–98)	219	75 (69–83)	396	78 (73–83)
1994–1998	184	72 (64–80)	362	79 (74–84)	30	85 (74–96)	216	77 (71–85)	416	79 (74–83)
1999–2003	209	68 (63–74)	396	81 (77–85)	34	85 (74–96)	243	82 (76–87)	371	81 (77–85)
Women
1964–1968	292	52 (47–58)	372	59 (54–64)	42	81 (66–98)	339	71 (67–76)	890	65 (62–68)
1969–1973	266	51 (46–57)	501	68 (64–72)	80	88 (80–96)	452	73 (69–77)	1 019	72 (69–74)
1974–1978	325	53 (48–58)	694	74 (70–78)	79	81 (72–92)	567	80 (77–84)	1 107	75 (72–77)
1979–1983	388	64 (59–69)	865	78 (75–81)	51	78 (67–92)	688	82 (79–86)	1 200	80 (78–82)
1984–1988	366	70 (65–75)	954	80 (77–83)	61	90 (83–98)	662	84 (81–88)	1 116	82 (79–84)
1989–1993	383	76 (71–81)	1 129	82 (80–85)	63	90 (83–98)	669	88 (84–91)	1 076	84 (81–86)
1994–1998	448	75 (71–80)	1 347	88 (86–90)	82	93 (87–99)	581	87 (84–91)	1 046	84 (82–87)
1999–2003	532	77 (73–80)	1 275	90 (88–91)	75	93 (87–99)	636	86 (83–89)	1 027	86 (84–88)

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival

*Too few patients to calculate survival, see ref. [17].

Table VI. Trends in 5-year age-specific relative survival in percent after thyroid cancer by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–49	50–59	60–69	70–79	80–89	90+	0–49	50–59	60–69	70–79	80–89	90 +
Denmark
1964–1968	73	41	36	23	66	*	84	50	37	25	9	*
1969–1973	85	35	13	12	39	*	85	47	34	23	6	*
1974–1978	78	44	26	16	31	*	88	48	33	23	14	*
1979–1983	82	46	43	19	0	*	92	54	56	37	35	*
1984–1988	85	43	49	28	0	*	98	84	52	37	17	0
1989–1993	94	62	42	37	103	*	95	81	80	43	23	*
1994–1998	85	69	72	61	32	*	97	89	59	55	21	*
1999–2003	92	78	57	29	48	*	97	90	67	50	26	0
Finland
1964–1968	87	57	43	9	0	*	86	64	51	25	11	*
1969–1973	87	57	43	9	0	*	95	80	59	28	19	*
1974–1978	91	70	66	27	0	*	97	82	59	46	43	*
1979–1983	99	84	49	60	33	*	99	88	74	47	28	*
1984–1988	96	79	67	36	34	*	98	95	72	51	33	0
1989–1993	95	83	68	63	28	*	99	95	79	59	27	77
1994–1998	96	85	87	47	22	*	100	99	88	70	41	0
1999–2003	96	86	85	47	52	*	100	100	90	75	42	2
Iceland
1964–1968	91	94	69	51	*	*	101	65	77	56	89	*
1969–1973	91	94	69	51	*	*	101	103	85	83	*	*
1974–1978	91	105	91	60	133	*	98	78	67	89	29	*
1979–1983	91	105	91	60	133	*	101	102	72	31	24	*
1984–1988	101	93	78	101	*	*	99	87	90	95	41	*
1989–1993	101	93	78	101	*	*	99	87	90	95	41	*
1994–1998	83	103	67	94	79	*	101	94	96	93	46	*
1999–2003	83	103	67	94	79	*	101	94	96	93	46	*
Norway
1964–1968	82	40	45	26	0	*	100	85	54	26	43	*
1969–1973	94	77	60	48	0	*	94	87	66	41	21	*
1974–1978	91	78	75	43	14	*	97	95	74	59	22	0
1979–1983	99	83	83	62	26	*	99	94	76	58	41	0
1984–1988	94	89	69	49	42	*	100	96	74	65	51	*
1989–1993	93	73	79	44	53	*	98	95	82	78	52	*
1994–1998	91	78	72	62	59	*	99	97	82	73	51	54
1999–2003	95	85	69	69	70	*	98	91	85	66	56	149
Sweden
1964–1968	84	61	38	25	26	*	95	77	48	28	12	*
1969–1973	88	64	41	24	13	*	97	81	64	37	20	0
1974–1978	94	70	54	32	17	*	98	85	71	38	27	30
1979–1983	91	81	62	44	20	*	99	88	74	57	35	45
1984–1988	95	80	68	48	5	*	99	93	75	60	34	47
1989–1993	93	82	67	61	62	*	99	91	74	71	42	45
1994–1998	96	78	70	67	42	*	99	96	78	66	42	22
1999–2003	95	83	76	68	48	*	99	96	85	66	36	19

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival

*Too few patients to calculate survival, see ref. [17].

Figure 6. Trends in age-standardised (ICSS) excess death rates per 100 person years for thyroid cancer by sex, country, and time since diagnosis in Nordic cancer survival study 1964–2003.

Figure 7. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for bone sarcoma by sex and country. Nordic cancer survival study 1964–2003.

Table VII. Trends in survival for bone sarcoma by sex and country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1968	124	38 (32–47)	173	21 (15–29)	4	*	89	39 (30–52)	218	40 (32–49)
1969–1973	167	38 (32–47)	161	35 (28–43)	11	*	69	39 (30–52)	221	52 (44–62)
1974–1978	131	55 (44–69)	145	39 (31–50)	9	*	125	41 (31–54)	228	43 (35–52)
1979–1983	122	39 (29–52)	142	45 (36–56)	9	*	105	56 (43–73)	247	59 (51–68)
1984–1988	131	47 (37–60)	123	53 (42–67)	7	*	109	48 (36–64)	228	56 (49–65)
1989–1993	120	47 (37–59)	98	53 (41–67)	10	*	114	39 (29–51)	218	62 (54–72)
1994–1998	148	51 (43–61)	136	56 (46–67)	10	*	114	54 (43–69)	201	63 (55–73)
1999–2003	128	55 (47–66)	116	62 (54–71)	7	*	129	54 (45–65)	202	64 (58–71)
Women
1964–1968	104	20 (12–32)	135	42 (33–54)	4	*	56	27 (17–42)	149	43 (34–54)
1969–1973	126	43 (33–56)	106	32 (24–42)	3	*	54	27 (17–42)	177	45 (37–56)
1974–1978	81	32 (21–50)	115	50 (41–62)	1	*	58	43 (29–63)	199	49 (41–58)
1979–1983	76	57 (44–74)	97	49 (39–63)	6	*	65	48 (35–66)	174	61 (53–70)
1984–1988	111	40 (32–50)	90	55 (45–68)	7	*	73	63 (48–81)	145	68 (59–78)
1989–1993	90	46 (36–60)	103	63 (52–77)	4	*	84	66 (54–80)	168	69 (61–78)
1994–1998	107	64 (53–77)	91	66 (55–80)	9	*	89	61 (51–74)	145	68 (60–78)
1999–2003	112	57 (48–67)	100	66 (57–76)	2	*	122	58 (49–68)	143	68 (61–76)

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival

*Too few patients to calculate survival, see ref. [17].

Table VIII. Trends in 5-year age-specific relative survival in percent after bone sarcoma by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–29	30–39	40–49	50–69	70–89	90+	0–29	30–39	40–49	50–69	70–89	90+
Denmark
1964–1968	34	42	64	36	24	*	31	22	22	21	11	*
1969–1973	34	42	64	36	24	*	39	54	54	47	23	*
1974–1978	39	50	68	69	29	*	47	43	46	26	24	*
1979–1983	35	39	58	45	14	*	42	61	61	64	43	*
1984–1988	43	67	71	44	26	*	60	81	81	14	28	*
1989–1993	59	61	85	37	26	*	55	77	77	37	22	*
1994–1998	62	82	71	55	11	*	64	74	74	67	44	*
1999–2003	62	68	72	56	33	*	66	59	59	65	38	*
Finland
1964–1968	47	23	59	13	0	*	43	59	59	35	33	*
1969–1973	40	73	71	27	0	*	43	63	63	26	0	*
1974–1978	39	71	67	40	0	*	57	69	69	56	15	*
1979–1983	48	62	69	45	18	*	50	71	71	42	34	*
1984–1988	61	73	64	60	17	*	61	82	82	52	26	*
1989–1993	57	80	79	43	35	*	68	77	77	62	47	*
1994–1998	58	67	66	61	30	*	66	65	65	76	50	*
1999–2003	70	71	64	68	43	*	76	76	76	73	37	*
Iceland
1964–1968	45	45	45	*	*	*	*	*	*	*	*	*
1969–1973	45	45	45	*	*	*	*	*	*	*	*	*
1974–1978	50	50	50	*	*	*	*	*	*	*	*	*
1979–1983	50	50	50	*	*	*	*	*	*	*	*	*
1984–1988	83	83	83	*	*	*	*	*	*	*	*	*
1989–1993	83	83	83	*	*	*	*	*	*	*	*	*
1994–1998	79	79	79	*	*	*	*	*	*	*	*	*
1999–2003	79	79	79	*	*	*	*	*	*	*	*	*
Norway
1964–1968	30	50	28	45	34	*	35	34	34	24	20	*
1969–1973	30	50	28	45	34	*	35	34	34	24	20	*
1974–1978	30	37	71	37	31	*	44	67	67	40	16	*
1979–1983	40	73	51	62	42	*	54	62	62	49	27	*
1984–1988	58	78	51	53	20	*	65	67	67	68	46	*
1989–1993	64	76	51	30	16	*	69	87	87	53	61	*
1994–1998	74	45	66	49	57	*	71	90	90	60	24	*
1999–2003	75	37	63	55	50	*	80	68	68	57	41	*
Sweden
1964–1968	30	58	49	43	20	*	39	60	55	45	24	*
1969–1973	42	74	72	48	37	*	44	50	61	45	33	*
1974–1978	47	67	51	36	36	*	55	74	72	48	19	*
1979–1983	54	57	91	60	37	*	61	73	74	57	50	*
1984–1988	51	65	73	64	27	*	69	89	84	72	38	*
1989–1993	67	59	85	64	44	*	64	100	76	66	52	*
1994–1998	64	78	69	62	53	*	76	80	87	77	30	0
1999–2003	61	77	76	66	46	*	76	69	81	77	41	*

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [17].

Figure 8. Trends in age-standardised (ICSS) excess death rates per 100 person years for bone sarcoma by sex, country, and time since diagnosis in Nordic cancer survival study 1964–2003. No Icelandic curves. Too few partients to calculate survival for Iceland.

Figure 9. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for soft tissue sarcoma by sex and country. Nordic cancer survival study 1964–2003.

Figure 10. Trends in age-standardised (ICSS) excess death rates per 100 person years for soft tissue sarcoma by sex, country, and time since diagnosis in Nordic cancer survival study 1964–2003. No Icelandic curves. Too few partients to calculate survival in Iceland.

Table IX. Trends in survival for soft tissue sarcoma by sex and country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1968	205	59 (51–67)	211	44 (38–51)	9	*	144	36 (28–46)	374	44 (39–50)
1969–1973	143	54 (45–65)	245	44 (38–51)	11	*	231	44 (37–51)	458	56 (51–61)
1974–1978	247	47 (40–54)	264	53 (46–61)	9	*	259	45 (39–52)	443	64 (59–70)
1979–1983	284	51 (44–58)	320	48 (42–55)	14	*	301	57 (51–64)	466	61 (56–66)
1984–1988	281	50 (44–58)	319	57 (51–64)	9	*	250	59 (52–67)	605	61 (56–66)
1989–1993	320	58 (52–65)	353	62 (56–68)	15	*	286	71 (65–78)	684	60 (56–64)
1994–1998	368	60 (54–66)	367	60 (55–65)	19	*	330	67 (61–73)	703	61 (57–65)
1999–2003	392	61 (57–66)	448	65 (61–70)	18	*	321	66 (62–71)	799	62 (59–66)
Women
1964–1968	179	55 (48–64)	222	47 (41–54)	8	*	128	47 (38–57)	310	49 (43–55)
1969–1973	168	58 (50–66)	286	46 (40–53)	9	*	176	48 (40–57)	395	55 (49–60)
1974–1978	211	49 (43–57)	289	52 (46–59)	8	*	249	57 (51–63)	405	63 (58–68)
1979–1983	221	57 (49–65)	292	60 (54–66)	11	*	276	58 (52–65)	484	60 (55–65)
1984–1988	239	55 (48–62)	356	58 (53–64)	14	*	250	65 (58–71)	564	60 (56–65)
1989–1993	300	57 (51–64)	397	64 (58–69)	12	*	273	66 (60–73)	608	53 (49–58)
1994–1998	295	64 (58–71)	409	66 (62–71)	10	*	241	70 (64–77)	636	61 (57–65)
1999–2003	350	64 (59–68)	416	67 (63–71)	9	*	280	71 (66–76)	640	63 (59–66)

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [17].

Table X. Trends in 5-year age-specific relative survival in percent after soft tissue sarcoma by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–49	50–59	60–69	70–79	80–89	90+	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	67	63	46	57	48	*	69	68	45	23	58	*
1969–1973	63	56	42	50	50	*	70	48	62	38	55	*
1974–1978	61	30	48	40	30	*	64	47	56	29	9	*
1979–1983	60	60	43	35	39	*	69	64	48	33	51	*
1984–1988	60	39	45	54	43	128	77	44	42	47	34	*
1989–1993	62	53	63	46	59	*	72	62	45	44	36	0
1994–1998	74	65	50	46	32	0	79	50	67	44	66	56
1999–2003	70	63	57	54	42	7	79	62	56	46	55	17
Finland
1964–1968	54	51	34	30	32	*	64	47	40	39	0	*
1969–1973	54	51	34	30	32	*	68	44	29	33	19	*
1974–1978	62	60	52	31	47	*	61	55	42	46	38	*
1979–1983	67	49	36	21	41	*	72	69	47	49	35	*
1984–1988	74	56	48	50	20	*	77	68	41	40	24	*
1989–1993	66	62	56	65	50	*	79	56	59	50	52	67
1994–1998	78	62	58	38	15	*	85	74	51	51	38	*
1999–2003	78	61	65	47	55	27	80	75	50	61	46	0
Iceland
1964–1968	36	36	36	81	*	*	65	65	65	*	*	*
1969–1973	36	36	36	81	*	*	65	65	65	*	*	*
1974–1978	56	56	56	55	*	*	71	71	71	*	*	*
1979–1983	56	56	56	55	*	*	71	71	71	*	*	*
1984–1988	51	51	51	37	*	*	56	56	56	*	*	*
1989–1993	51	51	51	37	*	*	56	56	56	*	*	*
1994–1998	61	61	61	*	*	*	70	70	70	*	*	*
1999–2003	81	81	81	*	*	*	70	70	70	*	*	*
Norway
1964–1968	28	28	31	70	39	*	59	52	32	27	60	*
1969–1973	53	47	41	28	32	*	52	56	53	33	21	*
1974–1978	62	47	41	32	0	97	82	54	48	28	27	*
1979–1983	72	52	54	36	54	*	72	64	53	40	32	0
1984–1988	75	55	49	35	69	*	86	59	53	47	39	0
1989–1993	76	87	58	65	55	*	75	77	57	58	36	0
1994–1998	80	75	60	55	26	0	76	72	75	63	37	0
1999–2003	74	75	64	50	44	8	79	74	66	60	56	0
Sweden
1964–1968	56	31	48	37	19	*	58	48	56	37	16	*
1969–1973	62	65	49	48	38	*	67	60	41	45	42	*
1974–1978	70	72	60	59	36	*	77	66	55	49	35	*
1979–1983	66	53	58	65	53	94	70	63	60	40	47	0
1984–1988	70	58	55	53	59	0	76	48	60	43	47	71
1989 – 1993	71	64	56	45	37	0	68	51	41	48	38	27
1994 – 1998	74	64	54	47	39	98	82	58	49	45	36	22
1999–2003	71	66	59	51	44	44	80	64	53	43	42	13

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival

Engholm G, Gislum M, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Material and methods. Acta Oncol; 2010.

 Google Scholar